Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Keratosis, Actinic 9Melanosis 3Carcinoma, Basal Cell 3Keratosis, Seborrheic 1Keratosis 1Condylomata Acuminata 1Carcinoma, Squamous Cell 1Carcinoma 1Bowen's Disease 1

Interventions

HhAntag691 15sonidegib 5cemiplimab 5Nivolumab 5Aminolevulinic Acid 5daromun 4Specimen Handling 4Radiotherapy 3Magnetic Resonance Spectroscopy 33-ingenyl angelate 3tazarotene 2relatlimab 2Ipilimumab 2IPI-926 2Drug Evaluation 2Celecoxib 2Biopsy 2talimogene laherparepvec 1remetinostat 1gusacitinib 1endonuclease V, phage T4 1X-Rays 1Triamcinolone 1Sutures 1Surgical Procedures, Operative 1Solutions 1Papillomavirus Vaccines 1Opdualag 1Observation 1Niacinamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Basal Cell × 3-ingenyl angelate × Clear all
NCT03546166 2023-07-21

PICABAS

Centre Hospitalier Universitaire de Nice

Phase 2 Completed
24 enrolled
Dermatologic

Carcinoma, Carcinoma, Basal Cell

NCT00108121 2015-01-19

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma

Peplin

Phase 2 Completed
60 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT00108134 2008-12-24

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma

Peplin

Phase 2 Completed
60 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡